CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 27  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0625
LYS 10.0625
GLU 20.0338
LEU 30.0168
ARG 40.0131
CYS 50.0167
GLN 60.0111
CYS 70.0120
ILE 80.0291
LYS 90.0249
THR 100.0103
TYR 110.0103
SER 120.0121
LYS 130.0096
PRO 140.0159
PHE 150.0093
HIS 160.0297
PRO 170.0183
LYS 180.0139
PHE 190.0131
ILE 200.0026
LYS 210.0170
GLU 220.0136
LEU 230.0114
ARG 240.0131
VAL 250.0090
ILE 260.0101
GLU 270.0190
SER 280.0102
GLY 290.0143
PRO 300.0302
HIS 310.0231
CYS 320.0162
ALA 330.0144
ASN 340.0133
THR 350.0088
GLU 360.0050
ILE 370.0059
ILE 380.0120
VAL 390.0136
LYS 400.0115
LEU 410.0099
SER 420.0416
ASP 430.0489
GLY 440.0062
ARG 450.0416
GLU 460.0332
LEU 470.0174
CYS 480.0071
LEU 490.0064
ASP 500.0081
PRO 510.0132
LYS 520.0400
GLU 530.0370
ASN 540.0625
TRP 550.0237
VAL 560.0077
GLN 570.0182
ARG 580.0082
VAL 590.0162
VAL 600.0168
GLU 610.0234
LYS 620.0251
PHE 630.0169
LEU 640.0175
LYS 650.0122
ARG 660.0139
ALA 670.0163
GLU 680.0247
ASN 690.0164

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.